goserelin has been researched along with Hypocalcemia* in 2 studies
2 other study(ies) available for goserelin and Hypocalcemia
| Article | Year |
|---|---|
Metastatic breast carcinoma presenting with profound hypocalcemia.
Hypocalcemia is a rare complication of malignancy. We present the case of a 30-year-old lady presenting with a grand mal seizure due to profound hypocalcemia. She was subsequently found to be hypoparathyroid and was diagnosed with metastatic breast carcinoma. Treatment with goserelin and exemestane produced a significant reduction in her tumor load and a correction of her hypocalcemia, which was initially refractory to treatment. We believe this to be the first case of metastatic breast carcinoma actually presenting with hypocalcemia and feel that clinicians should be aware of this rare complication. Topics: Adult; Androstadienes; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma; Epilepsy, Tonic-Clonic; Female; Goserelin; Humans; Hypocalcemia; Neoplasm Metastasis | 2010 |
The influence of cisplatinum and goserelinum on the magnesium and calcium level in rat serum.
The influence of cisplatinum and goserelinum on the magnesium and calcium concentration in rat serum has been studied. The cisplatinum induces decrease in serum magnesium concentration (to 70%), and calcium concentration (to 63%). Goserelinum activity was similar to cisplatinum activity. The magnesium concentration decreased to 60%, and calcium to 44%. In condition of cisplatinum and goserelinum activity the hypomagnesemia and hypocalcemia were noted. Topics: Animals; Antineoplastic Agents; Calcium; Cisplatin; Goserelin; Hypocalcemia; Magnesium; Rats; Rats, Wistar | 2001 |